Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

1.1K
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.1K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.3K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
Dementia01:30

Dementia

730
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
730
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

914
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
914
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Amnesia01:13

Amnesia

883
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
883

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External validation of dementia risk prediction models in the EPIC-Norfolk cohort: a UK-based cohort study.

NPJ dementia·2026
Same author

Global, regional and country-specific burden of dementia associated with depression across the life-course.

Archives of gerontology and geriatrics·2026
Same author

Sarcopenic obesity and dementia risk: Primary associations and landmark analyses of muscle strength and body composition trajectories.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Informing depression-specific dementia risk models: An evidence-based analysis of moderators of the depression-dementia association.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Dietary patterns and endothelium dysfunction: a literature review.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Association of sarcopenic obesity with dementia risk in a cohort of older women.

Clinical nutrition (Edinburgh, Scotland)·2026

Related Experiment Video

Updated: Apr 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Mild cognitive impairment definitions: more evolution than revolution.

Eugene Yh Tang1, Carol Brayne, Emiliano Albanese

  • 1Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK.

Neurodegenerative Disease Management
|February 26, 2015
PubMed
Summary

Early dementia detection is crucial for prevention. This study examines new criteria for Mild Cognitive Impairment (MCI), exploring their clarity and research implications for identifying individuals at risk.

Keywords:
Alzheimer's diseasebiomarkerscriteriadementiadiagnosismild cognitive impairmentprevention

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.2K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

4.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.2K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

4.0K

Area of Science:

  • Neurology
  • Gerontology
  • Psychiatry

Background:

  • Early identification of dementia risk is vital for secondary prevention.
  • Mild Cognitive Impairment (MCI) was proposed to bridge normal aging and dementia.
  • The clinical and research validity of MCI is currently debated.

Purpose of the Study:

  • To evaluate new criteria for Mild Cognitive Impairment (MCI).
  • To discuss the conceptual clarity of proposed MCI definitions.
  • To highlight the implications of these definitions for future research.

Main Methods:

  • Review of proposed diagnostic criteria for MCI.
  • Analysis of criteria from DSM-5, NIA-AA, and International Working Group.
  • Discussion of conceptual frameworks and research utility.

Main Results:

  • Multiple new criteria for MCI have been proposed.
  • These criteria include mild neurocognitive disorder (DSM-5).
  • The clarity and utility of these evolving definitions require further examination.

Conclusions:

  • New MCI criteria aim to refine the identification of individuals at risk for dementia.
  • Further research is needed to validate these definitions and their clinical implications.
  • Clarifying MCI conceptualization is essential for advancing dementia research and prevention.